Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$989.0K
28.99K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 28.99K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $989.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001950047-26-000904
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
28.99K
Shares to sell
$989.0K
Approx. market value
1.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
1/31/2026
1.75KTotal acquired1.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted Stock Not Applicable | 1.75K | — |
| Total | 1.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.24K
Market value
$232.6K
2/3/2026
—Completed
Units to sell
20K
Market value
$700.2K
12/1/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.75K
Market value
$56.2K
2/4/2026
Total
Units
28.99K
Value
$989.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 7.24K | $232.6K | — | Completed |
12/1/2025 | 20K | $700.2K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 1.75K | $56.2K | NASDAQ | Planned |
| Total | 28.99K | $989.0K | ||